L. Azoulay

First name
L.
Last name
Azoulay
Klil-Drori, A. J., Yin, H., Abenhaim, H. A., Fort, G. G. du, & Azoulay, L. (2017). Prolactin-Elevating Antipsychotics and the Risk of Endometrial Cancer. J Clin Psychiatry. http://doi.org/10.4088/JCP.15m10532
View
Wu, J. W., Azoulay, L., Majdan, A., Boivin, J. F., Pollak, M., & Suissa, S. (2017). Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women With Type 2 Diabetes. J Clin Oncol. http://doi.org/10.1200/jco.2017.73.4491
View
Hicks, B. M., Yin, H., Sinyavskaya, L., Suissa, S., Azoulay, L., & Brassard, P. (2017). Metformin and the incidence of viral associated cancers in patients with type 2 diabetes. Int J Cancer. http://doi.org/10.1002/ijc.30733
View
Hicks, B. M., Klil-Drori, A. J., Yin, H., Campeau, L., & Azoulay, L. (2017). Androgen Deprivation Therapy and the Risk of Anemia in Men with Prostate Cancer. Epidemiology. http://doi.org/10.1097/ede.0000000000000678
View
Khosrow-Khavar, F., Rej, S., Yin, H., Aprikian, A., & Azoulay, L. (2017). Androgen Deprivation Therapy and the Risk of Dementia in Patients With Prostate Cancer. J Clin Oncol. http://doi.org/10.1200/jco.2016.69.6203
View
Hicks, B. M., Yin, H., Bladou, F., Ernst, P., & Azoulay, L. (2017). Androgen deprivation therapy for prostate cancer and the risk of hospitalisation for community-acquired pneumonia. Thorax. http://doi.org/10.1136/thoraxjnl-2016-209512
View
Yu, O., Azoulay, L., Yin, H., Filion, K. B., & Suissa, S. (2018). Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia. Am J Med. http://doi.org/10.1016/j.amjmed.2017.09.044
View
Douros, A., Dell'Aniello, S., H. Y. Yu, O., Filion, K. B., Azoulay, L., & Suissa, S. (2018). Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study. Bmj. http://doi.org/10.1136/bmj.k2693
View
Douros, A., Abrahami, D., Yin, H., H. Y. Yu, O., Renoux, C., Hudson, M., & Azoulay, L. (2018). Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Diabetes. Epidemiology. http://doi.org/10.1097/ede.0000000000000891
View
Abrahami, D., Douros, A., Yin, H., Yu, O. H., Faillie, J. L., Montastruc, F., et al. (2018). Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study. Bmj. http://doi.org/10.1136/bmj.k4880
View